This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Eisai R&d Management Co., Ltd., Ucl Business Plc, Eisai Company, Limited. Active years: 2003-2023.
Company Filing History:
3 out of 530 
3 out of 299 
1 out of 677 
Years Active: 2003-2023
Title: The Ingenious Innovator: Shigeru Akasofu
Introduction: Shigeru Akasofu is a distinguished inventor hailing from Ibaraki, Japan. With a total of 4 patents to his name, he has made significant contributions to the field of biotechnology and pharmaceuticals.
Latest Patents: Among his recent patents is the groundbreaking invention of "Anti-Tau antibodies and uses thereof." These antibodies have proven to specifically bind Tau, opening up new avenues for treatment and therapy in neurodegenerative diseases. The focus on developing innovative solutions sets Akasofu apart in the world of inventors.
Career Highlights: Over the years, Shigeru Akasofu has lent his expertise to renowned companies such as Eisai R&D Management Co., Ltd. and UCL Business PLC. His commitment to research and development has led to the successful filing of patents that have the potential to revolutionize the medical field.
Collaborations: Collaboration plays a pivotal role in Akasofu's career, with notable coworkers like Malcolm Ian Roberts and James Martin Staddon. Together, they have worked on cutting-edge projects that have garnered attention in the scientific community.
Conclusion: In conclusion, Shigeru Akasofu stands out as a visionary inventor who continues to push the boundaries of innovation. His relentless pursuit of excellence and collaborative spirit serve as inspiration for aspiring inventors worldwide.